drugset / Trial / NCT05476172

The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis

NCT05476172

Completed 70 enrolled Uludag University
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized controlled study aims to investigate the efficiency of medical treatment modalities in endometriosis patients. The study protocol involves two arms. (Dienogest Group and Noretindrone Acetate Group). The patients diagnosed with endometriosis are randomized depending on their protocol ids. The Dienogest group is prescribed 5 mg dienogest per day and neta group is prescribed 5 mg neta per day. The pain scores will be analyzed six months and twelve months after treatment.

Timeline

Start
2021-04-01
Primary completion
2023-05-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dienogest Small molecule 2 mg Oral
Comparator Norethindrone Unknown 5 mg Oral

Indications